646 related articles for article (PubMed ID: 25333211)
1. Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy.
Salvatore S; Nappi RE; Parma M; Chionna R; Lagona F; Zerbinati N; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
Climacteric; 2015 Apr; 18(2):219-25. PubMed ID: 25333211
[TBL] [Abstract][Full Text] [Related]
2. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
Salvatore S; Nappi RE; Zerbinati N; Calligaro A; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
Climacteric; 2014 Aug; 17(4):363-9. PubMed ID: 24605832
[TBL] [Abstract][Full Text] [Related]
3. Fractional CO
Siliquini GP; Tuninetti V; Bounous VE; Bert F; Biglia N
Climacteric; 2017 Aug; 20(4):379-384. PubMed ID: 28503946
[TBL] [Abstract][Full Text] [Related]
4. Vaginal CO
Pearson A; Booker A; Tio M; Marx G
Breast Cancer Res Treat; 2019 Nov; 178(1):135-140. PubMed ID: 31377895
[TBL] [Abstract][Full Text] [Related]
5. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
[TBL] [Abstract][Full Text] [Related]
6. Microablative Fractional CO
Salvatore S; Nappi RE; Casiraghi A; Ruffolo AF; Degliuomini R; Parma M; Leone Roberti Maggiore U; Athanasiou S; Candiani M
Clin Breast Cancer; 2021 Oct; 21(5):e539-e546. PubMed ID: 33745867
[TBL] [Abstract][Full Text] [Related]
7. Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study.
Pagano T; De Rosa P; Vallone R; Schettini F; Arpino G; De Placido S; Nazzaro G; Locci M; De Placido G
Menopause; 2016 Oct; 23(10):1108-13. PubMed ID: 27648595
[TBL] [Abstract][Full Text] [Related]
8. Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors.
Pieralli A; Fallani MG; Becorpi A; Bianchi C; Corioni S; Longinotti M; Tredici Z; Guaschino S
Arch Gynecol Obstet; 2016 Oct; 294(4):841-6. PubMed ID: 27170261
[TBL] [Abstract][Full Text] [Related]
9. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
Vicariotto F; DE Seta F; Faoro V; Raichi M
Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
[TBL] [Abstract][Full Text] [Related]
10. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
Vicariotto F; Raichi M
Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
[TBL] [Abstract][Full Text] [Related]
11. Vulvovaginal atrophy of menopause and its impact on sexual function in an Italian clinical cohort of post-menopausal women.
Nappi RE; Guida M; Marchesoni D; Cianci A; Pellegrino A; Remorgida V; Di Paolantonio T; Benedetti Panici P;
J Obstet Gynaecol; 2021 Feb; 41(2):290-297. PubMed ID: 33432869
[TBL] [Abstract][Full Text] [Related]
12. The effects of fractional microablative CO
Gittens P; Mullen G
J Cosmet Laser Ther; 2019; 21(3):127-131. PubMed ID: 29883233
[TBL] [Abstract][Full Text] [Related]
13. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser.
Perino A; Calligaro A; Forlani F; Tiberio C; Cucinella G; Svelato A; Saitta S; Calagna G
Maturitas; 2015 Mar; 80(3):296-301. PubMed ID: 25596815
[TBL] [Abstract][Full Text] [Related]
14. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.
Nappi RE; Palacios S; Panay N; Particco M; Krychman ML
Climacteric; 2016 Apr; 19(2):188-97. PubMed ID: 26581580
[TBL] [Abstract][Full Text] [Related]
15. Fractional Co
Alexiades MR
Lasers Surg Med; 2021 Feb; 53(2):185-198. PubMed ID: 32329093
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of CO
Liu M; Li F; Zhou Y; Cao Y; Li S; Li Q
Int J Gynaecol Obstet; 2022 Aug; 158(2):241-251. PubMed ID: 34625949
[TBL] [Abstract][Full Text] [Related]
17. Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women.
Panay N; Palacios S; Bruyniks N; Particco M; Nappi RE;
Maturitas; 2019 Jun; 124():55-61. PubMed ID: 31097180
[TBL] [Abstract][Full Text] [Related]
18. New therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency.
Kamilos MF; Borrelli CL
Einstein (Sao Paulo); 2017; 15(4):445-451. PubMed ID: 29364367
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study.
Filippini M; Luvero D; Salvatore S; Pieralli A; Montera R; Plotti F; Candiani M; Angioli R
Menopause; 2020 Jan; 27(1):43-49. PubMed ID: 31794500
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]